Condition (MeSH)
Chemical and Drug Induced Liver Injury, Chronic
ClinicalTrials.gov lists 2 trials for Chemical and Drug Induced Liver Injury, Chronic or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
5 sections measured, none recorded · 1 not measured yet · 1 not computed
2 of the 2 trials are tagged with Chemical and Drug Induced Liver Injury, Chronic itself; the rest are tagged with a narrower condition beneath it.
When did Chemical and Drug Induced Liver Injury, Chronic trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2017 | 1 |
| 2015 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Chemical and Drug Induced Liver Injury, Chronic trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
How many Chemical and Drug Induced Liver Injury, Chronic trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Chemical and Drug Induced Liver Injury, Chronic? (10)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| M6229 Protects against Extracellular-Histone-Induced Liver Injury, Kidney Dysfunction, and Mortality in a Rat Model of Acute Hyperinflammation. | International journal of molecular sciences | 2024 | Yes |
| Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate. | Acta pharmacologica Sinica | 2023 | Yes |
| Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice. | eLife | 2022 | Yes |
| Leflunomide-induced liver injury: Differences in characteristics and outcomes in Indian and US registries. | Liver international : official journal of the International Association for the Study of the Liver | 2022 | Yes |
| Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial. | Alimentary pharmacology & therapeutics | 2022 | Yes |
Showing 5 of 10 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.